MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$926,058
Unit: Dollar
Positive Cash Flow Breakdown
Prepaid expense
Grants receivable
Accrued expenses
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Non-cash stock option expense
-
0
Net loss
-1,254,078
-2,634,009
Depreciation and amortization
722
1,443
Operating right of use asset
1,258
-849
Shares issued for services
-
0
Grants receivable
-41,981
-42,731
Prepaid expense
-389,921
265,761
Accounts payable
-145,219
219,920
Accrued expenses
19,852
-222,800
Payroll liability
19,505
62
Net cash used in operating activities
-926,057
-2,859,264
Proceeds from issuance of common stock, preferred stock, and/or pre-funded warrants, net of issuance costs
0
3,456,228
Net cash provided by financing activities
0
3,456,228
Net cash used in investing activities
-
0
Net decrease in cash, cash equivalents
-926,058
596,965
Cash and cash equivalents at beginning of period
2,184,863
-
Cash and cash equivalents at end of period
1,855,770
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in
cash, cash...
-$926,058
Prepaid expense
-$389,921
Grants receivable
-$41,981
Accrued expenses
$19,852
Payroll liability
$19,505
Operating right of use
asset
$1,258
Depreciation and
amortization
$722
Net cash used in
operating activities
-$926,057
Canceled cashflow
$473,239
Net loss
-$1,254,078
Accounts payable
-$145,219
Buy us a coffee
LIPELLA PHARMACEUTICALS INC. (LIPO)
LIPELLA PHARMACEUTICALS INC. (LIPO)